CRUS EVP exercises options and sells 1,458 shares
CIRRUS LOGIC, INC. executive Jeffrey W. Baumgartner reported a combination of option exercise and share sale.
Rhea-AI Filing Summary
CIRRUS LOGIC, INC. executive Jeffrey W. Baumgartner reported a combination of option exercise and share sale. He exercised 1,458 Incentive Stock Options at $68.56 per share to acquire the same number of common shares, then sold 1,458 common shares in an open-market sale at $145.97 per share.
These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026. After completing the exercise-and-sell sequence, he directly holds 16,405 common shares, indicating a relatively small, planned adjustment to his position rather than a large directional change.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 1,458 shares ($113K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Baumgartner Jeffrey W
Role
EVP, R&D
Sold
1,458 shs ($213K)
Approx. gross sale proceeds
$213K
Approx. exercise cost
$100K
Approx. pre-tax spread
$113K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 1,458 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,458 | $68.56 | $100K |
| Sale | Common Stock | 1,458 | $145.97 | $213K |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 0 contracts (Direct);
Common Stock — 16,405 shares (Direct)
Footnotes (2)
- F1. This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2026.
- F2. Only vested shares can be exercised under this option. 25% of the shares vested on 11/6/20; the remaining shares vested monthly over the following 36months so that the option was fully vested and exercisable on 11/6/23.
Key Figures
Shares sold: 1,458 shares
Sale price: $145.97/share
Options exercised: 1,458 shares
+4 more
7 metrics
Shares sold
1,458 shares
Open-market sale of common stock on July 1, 2026
Sale price
$145.97/share
Price received per share in the open-market sale
Options exercised
1,458 shares
Incentive Stock Option exercise into common stock
Exercise price
$68.56/share
Conversion price of Incentive Stock Option exercised
Shares held after
16,405 shares
Direct common stock ownership after transactions
Rule 10b5-1 plan adoption date
February 27, 2026
Date the pre-arranged trading plan was adopted
Option expiration
November 6, 2029
Expiration date of the Incentive Stock Option grant
Key Terms
Rule 10b5-1 plan, Incentive Stock Option, open-market sale, derivative exercise/conversion, +1 more
5 terms
Rule 10b5-1 plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Incentive Stock Option financial
"Incentive Stock Option (right to buy)"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
fully vested and exercisable financial
"so that the option was fully vested and exercisable on 11/6/23"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did CRUS executive Jeffrey Baumgartner report?
Jeffrey W. Baumgartner reported exercising 1,458 stock options and selling 1,458 common shares. The exercise price was $68.56 per share, and the sale price was $145.97 per share, reflecting a routine exercise-and-sell sequence.
What stock options did the CRUS executive exercise in this Form 4 filing?
He exercised 1,458 Incentive Stock Options with a conversion price of $68.56 per share, receiving 1,458 common shares. The option was fully vested and exercisable before this transaction, according to the vesting footnote.
Were the CRUS insider’s trades made under a Rule 10b5-1 trading plan?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Such plans pre-schedule trades, indicating these transactions were planned rather than opportunistic.
Did the CRUS insider retain any stock options after this Form 4 activity?
The filing’s derivative section shows the Incentive Stock Option for 1,458 shares now has a remaining balance of zero. This indicates those specific options were fully exercised with no remaining derivative position under that grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
